New hope for babies born with serious virus
NCT ID NCT06118515
Summary
This early-stage study aims to find a safe and effective dose of a new oral drug called letermovir for newborn infants with symptomatic congenital cytomegalovirus (CMV). The study will enroll 12 infants to see how their bodies process the drug and to check for any side effects. Infants will receive letermovir alongside the standard treatment, valganciclovir, for a short period to see if it helps better control the virus.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONGENITAL CYTOMEGALOVIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Children's National Medical Center - Sheikh Zayed Campus - Infectious Disease
WITHDRAWNWashington D.C., District of Columbia, 20010-2916, United States
-
Children's of Alabama Child Health Research Unit (CHRU)
RECRUITINGBirmingham, Alabama, 35233-0011, United States
-
Emory University School of Medicine
RECRUITINGAtlanta, Georgia, 30322-1014, United States
-
Louisiana State University Health Shreveport - Infectious Diseases
WITHDRAWNShreveport, Louisiana, 71101, United States
-
Medical College of Wisconsin
RECRUITINGMilwaukee, Wisconsin, 53226, United States
-
Nationwide Children's Hosp.-Neonatology-Ctr. for Perinatal Rsrch.
WITHDRAWNColumbus, Ohio, 43205-2664, United States
-
SUNY Upstate Medical University Hospital - Pediatrics
WITHDRAWNSyracuse, New York, 13210-2342, United States
-
University of Louisville School of Medicine - Norton Children's Hospital - Infectious Diseases
WITHDRAWNLouisville, Kentucky, 40202, United States
-
University of Minnesota - Pediatric Infectious Disease
WITHDRAWNMinneapolis, Minnesota, 55454, United States
-
University of Texas Southwestern Medical Center - Pediatrics
WITHDRAWNDallas, Texas, 75390-9063, United States
Conditions
Explore the condition pages connected to this study.